Mark S. Leventhal, Director at ProPhase Labs, Inc. (PRPH), bought 150,000 shares at $1.42 ($231K) on 2012-11-28, disclosed to the SEC on 2012-11-30.
Open-market purchase of $231k PRPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.42 | 47,300 | $67K | 29.0% |
| 2 | $1.60 | 102,700 | $164K | 71.0% |
| Total | $1.54 avg | 150,000 | $231K | 100% |
| Filing → |
| PRPH | BUY | 2013-05-10 | $16K | — | Filing → |